ArticleBlood advances2025

Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry.

Samuel John et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.